dallas semaglutide diarrhea class action A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Microdosing Ozempic: Benefits, risks and

During the process of follicular atresia, the accumulation of autophagosomes once reaching a certain level can induce apoptosis in GCs

SAGE Alsuwailem OA, et al

In August, a Louisiana resident who developed gastroparesis after taking both Ozempic and Mounjaro sued Novo Nordisk and Eli Lilly in a US District Court for failing to warn patients about the risks of gastrointestinal issues in relation to their medications, NBC News reported

Step 9: Appetite returns, and patients resume normal eating habits

During the COVID-era surge in demand for GLP-1 medications, Ozempic and Wegovy were both placed on the FDAs drug shortage list in 2022